Skip to main content
NVS logo
NVS
(NYSE)
Novartis AG
$154.03-- (--)
Loading... - Market loading

Novartis (NVS) Stock Price & Financial Analysis

Novartis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$153.16 - $154.81
52-Week High$170.46
52-Week Low$97.72
Open$153.37
Volume2.62M
Average Volume (3M)2.62M
Market Cap301.13B
Shares Outstanding1.96B
P/E Ratio (TTM)21.68
Forward P/E18.27
Price to Sales (P/S)5.35
Price to Book (P/B)6.57
EV/EBITDA14.25
Revenue (TTM)56.67B
Net Income (TTM)13.98B
Free Cash Flow (TTM)15.24B
EPS (TTM)$7.25
Profit Margin24.67%
Operating Margin31.13%
Return on Equity (ROE)30.31%
Debt to Equity0.73
50-Day MA$156.02
200-Day MA$134.39
52-Week Change41.48%
Annual Dividend$3.10
Dividend Yield2.00%
Payout Ratio42.80%
Last Dividend Ex-DateMar 11, 2026

Frequently Asked Questions About Novartis

What is the current stock price for NVS?

As of the latest trading session, NVS stock trades at $154.03. The 52-week range is $97.72–$170.46, with a day range of $153.16–$154.81.

What is the P/E ratio for NVS?

Novartis's trailing P/E ratio is 21.7, meaning investors pay $21.7 for every $1 of annual earnings. The forward P/E is 18.3, reflecting analyst expectations for future earnings. Novartis operates in the Healthcare sector.

Does NVS pay dividends?

Yes, Novartis pays a 2.00% annual dividend yield ($3.10 per share). The payout ratio is 42.8%. The last ex-dividend date was 2026-03-11.

What do analysts recommend for NVS?

Based on 2 analysts, the consensus for NVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVS?

Novartis's market capitalization is $301.13B, classifying it as a mega-cap company. Novartis operates in the Healthcare sector within the Drug Manufacturers - General industry.